nevirapine - CISMeF

Preferred Label : nevirapine;

MeSH definition : A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.;

CISMeF synonym : promeco brand of nevirapine; cahill may roberts brand of nevirapine;

MeSH hyponym : Nevirapine Hemihydrate; viramune; BI-RG-587; Hemihydrate, Nevirapine; BI RG 587; BIRG587;

MeSH CAS label : 6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-;

MeSH Related Number : 129618-40-2 (Nevirapine); B7XF2TD73C;

Registry Number MeSH : 129618-40-2;

Wikipedia link : https://en.wikipedia.org/wiki/Nevirapine;

Is substance : O;

UNII : 99DK7FVK1H;

InChIKey : NQDJXKOVJZTUJA-UHFFFAOYSA-N;

Details

Origin ID

D019829;

UMLS CUI

C0132326;

ATC code(s)
- nevirapine [ATC Code]
- stavudine, lamivudine and nevirapine [ATC Code]
- zidovudine, lamivudine and nevirapine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Nevirapine [LOINC component]
- Nevirapine [NCIt concept]
- Nevirapine (substance) [SNOMED CT concept]
Pharmacological action(s)
- Cytochrome P-450 CYP3A Inducers [MeSH Descriptor]
- Metabolic Side Effects of Drugs and Substances [MeSH Descriptor]
- anti-hiv agents [MeSH Descriptor]
- reverse transcriptase inhibitors [MeSH Descriptor]
Record concept(s)
- BI-RG-587 [MeSH concept]
- Nevirapine Hemihydrate [MeSH concept]
- nevirapine [MeSH concept]
- viramune [MeSH concept]
Related MeSH Supplementary Concept(s)
- 12-hydroxynevirapine sulfate [MeSH Supplementary Concept]
- 12-mesyloxynevirapine [MeSH Supplementary Concept]
- 2-chloro-5,11-dihydro-11--ethyl-5-methyl-8-phenylethyl-6H-dipyrido(3,2-b-2',3'-e)(1,4)diazepin-6-one [MeSH Supplementary Concept]
- 2-chloro-5,11-dihydro-11-ethyl-5-methyl-8-(2-(pyridin-4-yl)ethyl)-6H-dipyrido(3,2-b-2',3'-e)(1,4)diazepin-6-one [MeSH Supplementary Concept]
- 9-azido-5,6-dihydro-11-ethyl-6-methyl-11H-pyrido(2,3-b)(1,5)benzodiazepin-5-enone [MeSH Supplementary Concept]
- BI-RH 448 [MeSH Supplementary Concept]
- BI-RJ 70 [MeSH Supplementary Concept]
- stavudine, lamivudine, nevirapine drug combination [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Nevirapine [NCIt concept]
- Nevirapine [LOINC component]
- Nevirapine (substance) [SNOMED CT concept]
- Product containing nevirapine (medicinal product) [SNOMED CT concept]
- nevirapine [ATC Code]
Validated automatic mappings to BTNT
- nevirapine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients